Notable Labs, Ltd.

0.70 USD
+0.08 (+12.17%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Notable Labs, Ltd. stock is up 12.23% since 30 days ago. The next earnings date is Aug 15, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 30% of the previous 9 July’s closed higher than June.

About Notable Labs, Ltd.

Vascular Biogenics Ltd. develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. The company's lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the recurrent platinum-resistant ovarian cancer; and Phase II clinical trials treatment of recurrent glioblastoma and colorectal cancer.